Correction: Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis

Correction: Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis

Bibliographic Details
Main Author:	Tanima Ahmed
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-10-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/10/e036748corr1.full

Similar Items

Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis
by: Xiaofeng Zeng, et al.
Published: (2020-09-01)

Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
by: Piet Geusens, et al.
Published: (2008-04-01)

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
by: McQuay Henry J, et al.
Published: (2007-08-01)

Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase
by: Lluis Fajas, et al.
Published: (2003-09-01)

COMPARISON OF SELECTIVE AND NON SELECTIVE CYCLO-OXYGENASE 2 INHIBITORS IN EXPERIMENTAL COLITIS EXACERBATION: role of leukotriene B4 and superoxide dismutase
by: José Wander BREGANÓ, et al.
Published: (2014-09-01)

The potential of a cyclo-oxygenase-2 specific prostaglandin synthesis inhibitor for the prevention of preterm labour
by: Groom, Katie M.
Published: (2011)

Motion-Cyclo-oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs are as Safe as Placebo for the Stomach: Arguments for the Motion
by: Richard H Hunt
Published: (2003-01-01)

The biosynthesis of nitric oxide and its interactions with the cyclo-oxygenase pathway
by: Swierkosz, Tomasz Andrzej
Published: (1995)

The relationship between cyclo-oxygenase isoforms and platelets in the cardiothoracic system
by: Leadbeater, Philip David Mark
Published: (2012)

Role of cyclo-oxygenase and related pathways in vascular health and disease
by: Lundberg, Martina Helena
Published: (2012)

Motion – Cyclo-oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs are as Safe as Placebo for the Stomach: Arguments Against the Motion
by: Andreas Maetzel
Published: (2003-01-01)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
by: Alaa Rostom, et al.
Published: (2009-10-01)

The interrelationship between bradykinin and cyclo-oxygenase products in the rat small intestine
by: Walker, Roger
Published: (1979)

Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study
by: Abigail Hensley, et al.
Published: (2015-09-01)

Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
by: Shanzana Khan, et al.
Published: (2019-08-01)

Immunohistochemical Expression of Cyclo-oxygenase 2 and Liver X Receptor-α in Acne Vulgaris
by: Ola Ahmed Bakry, et al.
Published: (2017-09-01)

The in vitro free radical scavenging activity of tenidap, a new dual cyclo-oxygenase and 5-1ipoxygenase inhibitor
by: C. S. Lau, et al.
Published: (1992-01-01)

Inhibition of cyclo-oxygenase enzymes by paracetamol in nociception, temperature regulation and in culture cells
by: Ayoub, Samir Shawgy
Published: (2005)

The role of constitutive and inducible forms of nitric oxide synthase and cyclo-oxygenase in equine endotoxaemia
by: Farnfield, Belinda Alice
Published: (2003)

Efficacy of NSAIDs for the prevention of acute mountain sickness: a systematic review and meta-analysis
by: Anil Pandit, et al.
Published: (2014-09-01)

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer
by: Janice M Mehnert, et al.
Published: (2020-07-01)

CYCLO-OXYGENASE 2 IS PRESENT IN THE MAJORITY OF LESIONAL SKIN FROM PATIENTS WITH AUTOINMUNE BLISTERING DISEASES
by: Ana Maria Abreu Velez, et al.
Published: (2013-10-01)

Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
by: Maria Chiara Zatelli, et al.
Published: (2009-01-01)

Efficacy of Teprenone for Prevention of NSAID-Induced Gastrointestinal Injury: A Systematic Review and Meta-Analysis
by: Chongxiang Zhao, et al.
Published: (2021-04-01)

Genotoxicity of the cyclo-oxygenase-inhibitor sulindac sulfide in the filamentous fungus Aspergillus nidulans Genotoxicidade de sulfeto de sulindaco em Aspergillus nidulans
by: Claudinéia Conationi da Silva Franco, et al.
Published: (2007-09-01)

Pharmacoepidemiologic Research for Ischemic Stroke in Elderly Patients Who Taking Cyclo-oxygenase-2 inhibitors or Conventional Non-steroidal Anti-inflammatory Drugs
by: Ching-LanCheng, et al.
Published: (2010)

Régulation de la cyclo-oxygénase-2 dans les kératinocytes canins normaux et néoplasiques
by: Pronovost, Nadia
Published: (2016)

Correction: Vascular Endothelial Growth Factor Receptor-2 Couples Cyclo-Oxygenase-2 with Pro-Angiogenic Actions of Leptin on Human Endothelial Cells.
by: Elena Garonna, et al.
Published: (2019-01-01)

Protein-tyrosine-kinase-dependent expression of cyclo-oxygenase-1 and -2m RNAs in human endothelial cells
by: Hirai, Kennzo
Published: (2014)

Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
by: Derry Sheena, et al.
Published: (2004-08-01)

TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer.
by: Zhihong Yuan, et al.
Published: (2014-01-01)

Efficacy and tolerability of Guizhi-Shaoyao-Zhimu decoction in gout patients: a systematic review and Meta-analysis
by: Qing Zhang, et al.
Published: (2020-01-01)

Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout.
by: Liang Zhou, et al.
Published: (2014-01-01)

Clclo-oxygenase (COX) isoforms in the cardiovascular system : Implications for the future of COX-2 selective inhibitors
by: Hasan, Kamrul
Published: (2011)

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
by: Paglia Amelia, et al.
Published: (2006-07-01)

FCERI AND HISTAMINE METABOLISM GENE VARIABILITY IN SELECTIVE RESPONDERS TO NSAIDS
by: Gemma Amo, et al.
Published: (2016-09-01)

The medicinal chemistry of cyclo (Ser-Ser) and cyclo (Ser-Tyr)
by: Kritzinger, André Louis
Published: (2007)

The Anti-Inflammatory Effects of Lipoxygenase and Cyclo-Oxygenase Inhibitors in Inflammation-Induced Human Fetal Glia Cells and the Aβ Degradation Capacity of Human Fetal Astrocytes in an Ex vivo Assay
by: Rea Pihlaja, et al.
Published: (2017-05-01)

Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells.
by: Elena Garonna, et al.
Published: (2011-04-01)

Expression of cyclo-oxygenase-2 enzyme in the tissue samples of patients with various clinicopathological stages of oral leukoplakia and oral squamous cell carcinoma
by: Nelson Aruldoss, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_enbr8cr2elihgfpost8s17c20u